Bretylium Tosylate in the Treatment of Hypertension

スポンサーリンク

概要

• 論文の詳細を見る

• A seven months trial involving twenty-seven patients with the new hypotensive agent bretylium is described. This drug selectively blocks adrenergic nerve transmission and leads to marked postural falls in blood pressure. It is free from parasympathetic blocking effects such as blurred vision, constipation and bladder atony, but other, generally milder side effects have been noted. The drug is incompletely absorbed when given by mouth. Advantages and disadvantages of this new compound are discussed and its likely future place in the hypotensive drug regime has been considered.

• 社団法人日本循環器学会の論文
• 1961-05-15

著者

• Bauer C.e

  Cardio-vascular Clinic Sydney Hospital

• Bauer C.E.

  Cardio-Vascular Clinic, Sydney Hospital

関連論文

• Bretylium Tosylate in the Treatment of Hypertension

スポンサーリンク